| Pharmaceutical Information |
| Drug Name |
Teichomycin |
| Drug ID |
BADD_D02141 |
| Description |
Teicoplanin is a glycopeptide antibiotic consisting of a mixture of several compounds, five major (named teicoplanin A2-1 through A2-5) and four minor (named teicoplanin RS-1 through RS-4). All teicoplanins share a same glycopeptide core, teicoplanin A3-1, but differ in the length and conformation of side chains attached to their β-D-glucosamine moiety. |
| Indications and Usage |
For the treatment of bacterial infections caused by susceptible microorganisms. |
| Marketing Status |
approved; investigational |
| ATC Code |
J01XA02 |
| DrugBank ID |
DB06149
|
| KEGG ID |
D02142
|
| MeSH ID |
D017334
|
| PubChem ID |
16129701
|
| TTD Drug ID |
D0K6MW
|
| NDC Product Code |
Not Available |
| UNII |
4U3D3YY81M
|
| Synonyms |
Teicoplanin | Teichomycin | Teichomycin A2 | Targocid |
|
| Chemical Information |
| Molecular Formula |
C88H97Cl2N9O33 |
| CAS Registry Number |
61036-62-2 |
| SMILES |
CCCCCCCCCC(=O)NC1C(C(C(OC1OC2=C3C=C4C=C2OC5=C(C=C(C=C5)C(C6C(=O)NC(C7=C(C(=CC(=C
7)O)OC8C(C(C(C(O8)CO)O)O)O)C9=C(C=CC(=C9)C(C(=O)N6)NC(=O)C4NC(=O)C1C2=CC(=CC(=C2
)OC2=C(C=CC(=C2)C(C(=O)NC(CC2=CC(=C(O3)C=C2)Cl)C(=O)N1)N)O)O)O)C(=O)O)OC1C(C(C(C
(O1)CO)O)O)NC(=O)C)Cl)CO)O)O |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
